Gultekin, M. Et Al. 2019. Investigation of the Effects of Propranolol on DRD3, SLC1A2 and HTRA2 Gene Expression in Patients with Essential Tremor. International Congress of Parkinson's Disease and Movement Disorders , (Nice, France).

Gultekin, M., Kandemir, N., Mirza, M., Kara, M., Tascioglu, N., & Dundar, M., (2019). Investigation of the Effects of Propranolol on DRD3, SLC1A2 and HTRA2 Gene Expression in Patients with Essential Tremor . International Congress of Parkinson's Disease and Movement Disorders, Nice, France

Gultekin, M. Et Al. "Investigation of the Effects of Propranolol on DRD3, SLC1A2 and HTRA2 Gene Expression in Patients with Essential Tremor," International Congress of Parkinson's Disease and Movement Disorders, Nice, France, 2019

Gultekin, M. Et Al. "Investigation of the Effects of Propranolol on DRD3, SLC1A2 and HTRA2 Gene Expression in Patients with Essential Tremor." International Congress of Parkinson's Disease and Movement Disorders , Nice, France, 2019

Gultekin, M. Et Al. (2019) . "Investigation of the Effects of Propranolol on DRD3, SLC1A2 and HTRA2 Gene Expression in Patients with Essential Tremor." International Congress of Parkinson's Disease and Movement Disorders , Nice, France.

@conferencepaper{conferencepaper, author={M. Gultekin Et Al. }, title={Investigation of the Effects of Propranolol on DRD3, SLC1A2 and HTRA2 Gene Expression in Patients with Essential Tremor}, congress name={International Congress of Parkinson's Disease and Movement Disorders}, city={Nice}, country={France}, year={2019}}